https://scholars.lib.ntu.edu.tw/handle/123456789/473375
標題: | Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells | 作者: | Kao Y.-C. Lin M.-C. WEI-CHOU LIN YUNG-MING JENG TSUI-LIEN MAO |
公開日期: | 2012 | 卷: | 61 | 期: | 5 | 起(迄)頁: | 760-768 | 來源出版物: | Histopathology | 摘要: | Aims: Overexpression of hepatocyte nuclear factor-1β (HNF-1β) has been found in ovarian clear cell carcinoma (OCCC) but not in other types of ovarian carcinoma. The aim of this study was to clarify whether the overexpression of HNF-1β is specific for OCCC, and does not occur in ovarian carcinoma with clear cell change. Methods and results: Immunohistochemistry was performed on 178 ovarian carcinomas with clear cells (80 OCCCs, 60 high-grade serous, 25 endometrioid, and 13 mixed endometrioid and clear cell), 22 ovarian high-grade serous carcinomas without clear cells, 41 renal cell carcinomas (RCCs) and 20 hepatocellular carcinomas (HCCs) with clear cytoplasm. Results were evaluated using an H-score (percentage×intensity). Most OCCCs were diffusely and strongly positive (mean H-score 15.1). High-grade serous carcinoma and endometrioid carcinoma with clear cells were usually negative or focally and weakly positive (mean H-scores 1.5 and 1.7, respectively). High-grade serous carcinoma without clear cells had a mean H-score of 0.77. The mean H-scores of the endometrioid and clear cell components in mixed endometrioid and clear cell carcinoma were 6.2 and 15.7, respectively. HNF-1β was expressed in 95.1% of RCCs and in 30% of HCCs. Conclusions: The diagnosis of ovarian carcinomas with clear cells can be made with greater accuracy by using the intensity and extent of immunoreactivity for HNF-1β. ? 2012 Blackwell Publishing Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868126411&doi=10.1111%2fj.1365-2559.2012.04267.x&partnerID=40&md5=2693b986a496b05868193b4c8b8dc9b9 https://scholars.lib.ntu.edu.tw/handle/123456789/473375 |
ISSN: | 0309-0167 | DOI: | 10.1111/j.1365-2559.2012.04267.x | SDG/關鍵字: | hepatocyte nuclear factor 1beta; tumor marker; article; cancer diagnosis; cancer grading; clear cell carcinoma; controlled study; cytoplasm; diagnostic value; differential diagnosis; endometrioid carcinoma; female; human; human tissue; immunohistochemistry; kidney carcinoma; liver cell carcinoma; major clinical study; ovary carcinoma; priority journal; protein expression; scoring system; Adenocarcinoma, Clear Cell; Carcinoma, Endometrioid; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cystadenocarcinoma, Serous; Female; Hepatocyte Nuclear Factor 1-beta; Humans; Immunohistochemistry; Kidney Neoplasms; Liver Neoplasms; Ovarian Neoplasms; Tumor Markers, Biological |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。